Skip to main content

Table 1 Comparison of general demographic data between the two groups

From: Application of comprehensive unit-based safety program model to improve chemotherapy-induced nausea and vomiting in patients with ovarian cancer: a retrospective study

Variables

Categories

The intervention group (n = 45)

The control

group (n = 45)

T /\({ \chi }^{2}\)

P

Age

 

54.87 ± 10.51

55.93 ± 12.92

-0.430

0.668

Level of education

Primary or below

31

33

2.196

0.533

Junior high

9

9

Senior high / technical secondary

4

1

Undergraduate / Junior college or above

1

2

Place of residence

Rural

33

36

0.559

0.455

Urban

12

9

Employment

Employed

12

8

1.029

0.310

Unemployed

33

37

Vomiting of pregnancy

Yes

34

33

0.058

0.809

No

11

12

Pathological type

Epithelial carcinoma of the ovary

43

40

1.442

0.486

Malignant germ cell tumor of ovary

1

3

Malignant ovarian cord-stromal tumor

1

2

Relapse

No

31

34

0.498

0.480

Yes

14

11

Chemotherapy regimens

TP regimensa

24

23

1.807

0.613

EP regimensb

2

5

DC regimensc

5

3

Othersd

14

14

The score of KPSe

70–90

10

13

0.526

0.468

>90

35

32

  1. a: Cis-platinum + Paclitaxel; b: Etoposide + Paclitaxel; c: Docetaxel + Carboplatin;
  2. d: Doxorubicin hydrochloride + Carboplatin; Topotecan + Bevacizumab; Paclitaxel + Carboplatin + Bevacizumab; Apatinib mesylate + Etoposide;
  3. e: Karnofsky performance status